Schedule 13G ownership disclosure
ENTERA BIO LTD
Ordinary Shares, par value of NIS 0.0000769 · CUSIP: M40527109
Event date: 2026-10-23
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Venrock Healthcare Capital Partners III, L.P.
Shares: 8,861,763.00 · Class: 5.1%
- VHCP Co-Investment Holdings III, LLC
Shares: 8,861,763.00 · Class: 5.1%
- Venrock Healthcare Capital Partners EG, L.P.
Shares: 8,861,763.00 · Class: 5.1%
- VHCP Management III, LLC
Shares: 8,861,763.00 · Class: 5.1%
- VHCP Management EG, LLC
Shares: 8,861,763.00 · Class: 5.1%
- Nimish Shah
Shares: 8,861,763.00 · Class: 5.1%
- Bong Y. Koh
Shares: 8,861,763.00 · Class: 5.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001738048-26-000079
- Form type
- SCHEDULE 13G
- Filer
- Venrock Healthcare Capital Partners III, L.P.
- CIK
- CIK 1738048
- Filed
- Oct 30, 2026
- Reporting period
- Oct 23, 2026
- Description
- Schedule 13G beneficial ownership